My Healthy Maryland im Vergleich zu Noro202 Study Nutzung und Statistiken

My Healthy Maryland Precision Health Initiative is a long-term research study. It will create a diverse “biobank” of health data and samples that can be used for research to understand how genes and other factors affect health and disease. Results from this study will lead to better ways to individualize or “personalize” healthcare (called “Precision Health”). WHY SHOULD I JOIN? By joining the My Healthy Maryland Precision Health Initiative, you help advance medical research and the wellbeing of society. The research may lead to improved healthcare that brings new hope for people with different conditions or diseases, including ones that are common in your community. You may learn about your health, which could lead to a better quality of life for yourself and your family members. WHO CAN JOIN? - Any person aged 18 or older who currently lives in Maryland. - Anyone who can consent for themselves in English. - Persons who are incarcerated cannot join the study at this time. WHO CAN USE MY INFORMATION AND SAMPLES? The My Healthy Maryland Precision Health Initiative Team can use your samples and data for research. Other approved researchers from the University of Maryland and from outside of the University of Maryland can ask to use your data and samples. Each request will first be evaluated by the My Healthy Maryland Precision Health Initiative Advisory Committee. All research requests must further be approved by an Institutional Review Board (IRB). An IRB is a special committee that protects the rights and welfare of research participants. We will protect your privacy and secret information when we share your samples or data. Your name or other identifiers will NEVER be shared with anyone outside of the My Healthy Maryland Precision Health Initiative Team. ***** Discover a healthier future together! Join the My Healthy Maryland Precision Health Initiative today.
  • Apple App Store
  • Kostenlos
  • Gesundheit und Fitness

Rang speichern

- -

Welcome to the Noro202 Study: The purpose of this study is to assess the immune response of the Bivalent GI.1/GII.4 vaccine against Norovirus in healthy adults, as well as how safe the vaccine is. New (investigational) medications, drugs and devices must be approved for use by the United States Food and Drug Administration (FDA). The Bivalent GI.1/GII.4 vaccine is an experimental vaccine. This means that it is not an approved vaccine to prevent healthy adults from acquiring Norovirus in the United States or in any other country. This research is being sponsored and conducted by Vaxart Inc. Subject Journey A subject who is identified as eligible for this study during screening will be invited to download the Noro202 Study App via e-mail. Upon download, the participants create an account and is contacted by a study team member to complete the Informed Consent process. A series of screens explains the parameters of the study, including: o Privacy Policy o Data Gathering & Usage o Study Tasks & Surveys o Time Commitment o Option to Withdraw Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form. Intervention Period: Daily Tasks Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and 8 day active trial period. Subjects can interact with the study team via secure chat as needed.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

My Healthy Marylandvs. Noro202 Study Ranking-Vergleich

Vergleichen Sie My Healthy Maryland den Ranking-Trend der letzten 28 Tage mit Noro202 Study

Rang

Keine Daten verfügbar

My Healthy Maryland im Vergleich zu Noro202 Study Ranking im Ländervergleich

Vergleichen Sie My Healthy Maryland den Ranking-Trend der letzten 28 Tage mit Noro202 Study

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
My Healthy Maryland VS.
Noro202 Study

Dezember 11, 2024